FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

28974211000001107: BecoAllergy 10mg tablets (Omega Pharma Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
91068301000001113 BecoAllergy 10mg tablets (Omega Pharma Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
91068401000001117 BecoAllergy 10mg tablets (Omega Pharma Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
BecoAllergy 10mg tablets (Omega Pharma Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
BecoAllergy 10mg tablets (Omega Pharma Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
BecoAllergy 10mg tablets (Omega Pharma Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
BecoAllergy 10mg tablets (Omega Pharma Ltd) 30 tablet Is a Cetirizine 10mg tablets 30 tablet true Inferred relationship Existential restriction modifier
BecoAllergy 10mg tablets (Omega Pharma Ltd) 30 tablet Has AMP BecoAllergy 10mg tablets (Omega Pharma Ltd) true Inferred relationship Existential restriction modifier
BecoAllergy 10mg tablets (Omega Pharma Ltd) 30 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
BecoAllergy 10mg tablets (Omega Pharma Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
BecoAllergy 10mg tablets (Omega Pharma Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
BecoAllergy 10mg tablets (Omega Pharma Ltd) 30 tablet Has specific active ingredient Cetirizine hydrochloride true Inferred relationship Existential restriction modifier
BecoAllergy 10mg tablets (Omega Pharma Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
BecoAllergy 10mg tablets (Omega Pharma Ltd) 30 tablet Legal category General sales list true Inferred relationship Existential restriction modifier
BecoAllergy 10mg tablets (Omega Pharma Ltd) 30 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
BecoAllergy 10mg tablets (Omega Pharma Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
BecoAllergy 10mg tablets (Omega Pharma Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start